SUCCINYLACETONE QUANTITATIVE / URINE

image not found

NABL Cap Accredited   
The Succinylacetone Quantitative test measures the level of succinylacetone in urine, a key marker used for diagnosing Tyrosinemia Type I. Elevated levels indicate impaired tyrosine metabolism due to fumarylacetoacetate hydrolase deficiency. This test is essential for early detection, monitoring treatment response, and guiding long-term management. Metropolis Healthcare performs this assay using highly sensitive chromatographic techniques to ensure precise and reliable quantification.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,030.00

Sample Type: URINE

Fasting Not Required


Notes: S0085

Frequently Asked Questions (FAQ's):

What is succinylacetone?
It is an abnormal metabolite that builds up in Tyrosinemia Type I due to a genetic enzyme deficiency.

Why is this test done?
To diagnose Tyrosinemia Type I, monitor therapy, or evaluate infants with suspected metabolic disorders.

Is any preparation required?
No fasting or special preparation is needed for this urine test.

What sample is required?
A urine sample, preferably the first morning sample for best accuracy.

How is the test performed?
It is performed using advanced chromatographic methods such as LC-MS/MS for accurate quantification.

Can this test be used for newborn screening?
Yes, it is an important confirmatory test when initial newborn screening suggests metabolic abnormalities.

What conditions can elevated levels indicate?
Primarily Tyrosinemia Type I, but levels may also rise with severe liver dysfunction associated with the disorder.

Does Metropolis Healthcare offer this test?
Yes, Metropolis Healthcare provides this test with high analytical accuracy and reliability.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab